Vaccine News and Research

Latest Vaccine News and Research

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.

25 Jul 2020

National clinical trial to test potential vaccine against SARS-CoV-2

UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

25 Jul 2020

Animal Free Research UK condemns the wasted opportunity to make real progress in reducing animal experiments

Animal Free Research UK has today condemned yet another wasted opportunity to make real progress with a decrease of just 3.4% in experiments on animals in GB laboratories in 2019, announced by the Home Office this morning.

25 Jul 2020

Elevated leptin levels may explain why COVID-19 is so dangerous for people with obesity

A hormone that connects the body's metabolism and immune response system may explain why COVID-19 is so dangerous for people with obesity.

24 Jul 2020

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.

24 Jul 2020

COVID-19: Models highlight the dangers of relaxing public health measures

If physical distancing measures in the United States are relaxed while there is still no COVID-19 vaccine or treatment and while personal protective equipment remains in short supply, the number of resulting infections could be about the same as if distancing had never been implemented to begin with, according to a UCLA-led team of mathematicians and scientists.

24 Jul 2020

Study shows how protective T cells become pathogenic in atherosclerosis

High cholesterol kills. In fact, one in four Americans will die from the consequences of atherosclerosis, the buildup of plaques of fat and cholesterol in the arteries. Statins have helped reduce mortality, but millions are still at risk.

24 Jul 2020

Researchers design new version of protein to develop COVID-19 vaccine

Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.

24 Jul 2020

Modulating immunometabolic processes to control lung infection

When drugs to kill microbes are ineffective, host-directed therapy uses the body's own immune system to deal with the infection.

23 Jul 2020

Engineered SARS-CoV-2 spike protein is more stable and can generate larger yields in the lab

A team of scientists has engineered the spike protein of the SARS-CoV-2 virus - a critical component of potential COVID-19 vaccines - to be more environmentally stable and generate larger yields in the lab.

23 Jul 2020

New article sheds light on challenges faced by vaccine developers

With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don't all agree on how to get there and what "effective" really means.

23 Jul 2020

New biomolecules can benefit agricultural and pharmaceutical sectors

These molecules of plant origin may be of use to the agricultural and pharmaceutical sectors. Researchers from the Biochemistry and Biotechnology Research Group at the Universitat Jaume Ihave identified and obtained biomolecules of plant origin, which have been tested against plant pathogens and pathogens of clinical interest, with the aim of obtaining high-quality commercial products that can be applied in the agricultural and pharmaceutical sectors.

23 Jul 2020

Findings could help design vaccines against coronavirus

Scientists investigating the evolution of the virus that causes Covid19 say that its mutation seems to be directed by human proteins that degrade it, but natural selection of the virus enables it to bounce back. The findings could help in the design of vaccines against the virus.

23 Jul 2020

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Study shows parental hesitancy to begin and complete child's HPV vaccine series

Study results documenting parental hesitancy to begin and complete their child's HPV vaccine series were published in The Lancet Public Health by researchers at The University of Texas Health Science Center at Houston.

22 Jul 2020

Scientists want to know more about using UV light to fight COVID-19 spread

High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.

22 Jul 2020

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.

22 Jul 2020

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.

22 Jul 2020

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Thermo Fisher Scientific Inc., the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally.

From Thermo Fisher Scientific Inc. 22 Jul 2020

Survey: Almost 60% of parents are reluctant to protect their children from HPV

22 Jul 2020

Vaccine News and Research

Latest Vaccine News and Research

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

National clinical trial to test potential vaccine against SARS-CoV-2

Animal Free Research UK condemns the wasted opportunity to make real progress in reducing animal experiments

Elevated leptin levels may explain why COVID-19 is so dangerous for people with obesity

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

COVID-19: Models highlight the dangers of relaxing public health measures

Study shows how protective T cells become pathogenic in atherosclerosis

Researchers design new version of protein to develop COVID-19 vaccine

Modulating immunometabolic processes to control lung infection

Engineered SARS-CoV-2 spike protein is more stable and can generate larger yields in the lab

New article sheds light on challenges faced by vaccine developers

New biomolecules can benefit agricultural and pharmaceutical sectors

Findings could help design vaccines against coronavirus

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Study shows parental hesitancy to begin and complete child's HPV vaccine series

Scientists want to know more about using UV light to fight COVID-19 spread

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Survey: Almost 60% of parents are reluctant to protect their children from HPV

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Newsletters you may be interested in